ANRG -- Anergen -- new CEO big chance ? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANRG -- Anergen -- new CEO big chance ?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tonyt who wrote (22)	7/7/1997 4:35:00 PM
From: Russ B.	of 123

What makes Anergen a good buy at $3? I agree, they do have enough cash to last several years. From what I hear, they have an MS drug and an arthritis drug in clinical trials, but some other companies are ahead of them in the race. These drugs would have huge potential markets obviously. But does anyone know how things are going with the testing? What makes us think this company will be the one to pull it off?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next